European Sleep Apnea Devices Market, by Segment (Sleep Apnea Diagnostic Devices (Home Sleep Testing, Respiratory Polygraphs, Actigraphy Systems) and Sleep Apnea Therapeutic Devices (Pap Devices, Oxygen Devices, Airway Clearance Systems) - Forecast to 2019
The European sleep apnea devices market is projected to grow at a CAGR of 16.0% from 2014 to 2019. Germany holds the largest share of the European sleep apnea devices market. This large share of the German segment is attributed to the various driving forces, such as the increasing prevalence of sleep disorders in this region, increasing awareness level among patients and caregivers, rising number of cases of cardiovascular disorders, and the availability of technologically advanced diagnostic and therapeutic devices. However, the inadequate reimbursement coverage and patient compliance are perceived to hinder the growth of this market in the coming years. The high costs associated with the diagnosis and treatment of sleep apnea also restrains the growth of devices market in this region.
The research report classifies the European sleep apnea devices market on the basis of segment into sleep apnea therapeutic devices and sleep apnea diagnostic devices. The sleep apnea therapeutic devices is further segmented based on types into home sleep testing/portable monitoring, sleep labs, respiratory polygraphs, two channel screening devices, single channel screening devices, and actigraphy systems. Similarly, the sleep apnea therapeutic devices market is segmented based on the types into Positive Airway Pressure (PAP) devices, masks, adaptive servo-ventilation, airway clearance systems, oxygen devices, and oral appliances. The PAP devices segment is the largest contributor in the therapeutic devices market. Moreover, the therapeutic devices segment is the largest contributor to the overall European sleep apnea devices market, having accounted for a share of 58.1% in 2014.
Further, the European sleep apnea devices market is segmented based on the major countries of the region, such as Germany, France, the U.K., Italy, Spain, and the Rest of Europe (RoE). Germany is the largest market for sleep apnea devices in Europe. It accounted for a share of 27.9% of the European sleep apnea devices market in 2014. The major factors contributing to its dominance are the increasing prevalence of sleep disorders, rising awareness among patients and caregivers, and availability of advanced diagnosis and therapy options. France is the second-largest market in Europe and is projected to grow at a CAGR of 16.6% from 2014 to 2019. The U.K. houses the fastest-growing segment of the European sleep apnea devices market, and is projected to grow at the fastest CAGR from 2014 to 2019. The rising research & development activities pertaining to sleep disorders, rising obesity rates, and increasing awareness levels among patients and caregivers, are some of the factors expected to drive the growth of the European sleep apnea devices market in the coming years.
The report has profiled the leading players of this market, along with the developments (New product launches, partnerships, agreements, collaborations, and joint ventures) done by the companies over the past few years and strategies adopted by them to sustain and strengthen their positions in the European sleep apnea devices market. Philips Respironics, a subsidiary of Philips Healthcare (Netherlands); ResMed (U.S.); Compumedics Limited (Australia); Carefusion Corporation (U.S.); BMC Medical Co., Ltd. (China); Natus Medical Incorporated (U.S.); Fisher and Paykel Healthcare, Ltd. (New Zealand); DeVilbiss Healthcare (U.S.); Itamar Medical, Ltd. (U.S.); and Weinmann Medical Devices GmbH & Co. KG (Germany) are among the key players operational in this market.
Reasons to Buy the Report:
From an insight perspective, this research report has focused on various levels of analysis—industry analysis (industry trends and PEST analysis), market share analysis of top players, supply chain analysis, and company profiles, which together provide basic views on the competitive landscape, usage patterns, emerging and high-growth segments of the European sleep apnea devices market, high-growth regions, countries and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities in the market.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater share in the market. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market share.
The report provides insights on the following pointers:
The research report classifies the European sleep apnea devices market on the basis of segment into sleep apnea therapeutic devices and sleep apnea diagnostic devices. The sleep apnea therapeutic devices is further segmented based on types into home sleep testing/portable monitoring, sleep labs, respiratory polygraphs, two channel screening devices, single channel screening devices, and actigraphy systems. Similarly, the sleep apnea therapeutic devices market is segmented based on the types into Positive Airway Pressure (PAP) devices, masks, adaptive servo-ventilation, airway clearance systems, oxygen devices, and oral appliances. The PAP devices segment is the largest contributor in the therapeutic devices market. Moreover, the therapeutic devices segment is the largest contributor to the overall European sleep apnea devices market, having accounted for a share of 58.1% in 2014.
Further, the European sleep apnea devices market is segmented based on the major countries of the region, such as Germany, France, the U.K., Italy, Spain, and the Rest of Europe (RoE). Germany is the largest market for sleep apnea devices in Europe. It accounted for a share of 27.9% of the European sleep apnea devices market in 2014. The major factors contributing to its dominance are the increasing prevalence of sleep disorders, rising awareness among patients and caregivers, and availability of advanced diagnosis and therapy options. France is the second-largest market in Europe and is projected to grow at a CAGR of 16.6% from 2014 to 2019. The U.K. houses the fastest-growing segment of the European sleep apnea devices market, and is projected to grow at the fastest CAGR from 2014 to 2019. The rising research & development activities pertaining to sleep disorders, rising obesity rates, and increasing awareness levels among patients and caregivers, are some of the factors expected to drive the growth of the European sleep apnea devices market in the coming years.
The report has profiled the leading players of this market, along with the developments (New product launches, partnerships, agreements, collaborations, and joint ventures) done by the companies over the past few years and strategies adopted by them to sustain and strengthen their positions in the European sleep apnea devices market. Philips Respironics, a subsidiary of Philips Healthcare (Netherlands); ResMed (U.S.); Compumedics Limited (Australia); Carefusion Corporation (U.S.); BMC Medical Co., Ltd. (China); Natus Medical Incorporated (U.S.); Fisher and Paykel Healthcare, Ltd. (New Zealand); DeVilbiss Healthcare (U.S.); Itamar Medical, Ltd. (U.S.); and Weinmann Medical Devices GmbH & Co. KG (Germany) are among the key players operational in this market.
Reasons to Buy the Report:
From an insight perspective, this research report has focused on various levels of analysis—industry analysis (industry trends and PEST analysis), market share analysis of top players, supply chain analysis, and company profiles, which together provide basic views on the competitive landscape, usage patterns, emerging and high-growth segments of the European sleep apnea devices market, high-growth regions, countries and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities in the market.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater share in the market. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market share.
The report provides insights on the following pointers:
- Product Analysis and development: Detailed insights on upcoming technologies, research & development activities, and new product launches in the European sleep apnea devices market, along with usage patterns/penetration rate (in-depth trend analysis) of products (segment-wise) and purchasing data. This analysis also includes a comprehensive coverage of product approvals, patent analysis, pipeline products, and product recalls.
- Market Development: Comprehensive information about lucrative emerging markets, through analysis conducted across the criteria of geographies, distribution channels, clientele base, and different pricing policies
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments decisions in the sleep apnea devices market, along with a detailed description regarding the related and unrelated diversification pertaining to this market
- Epidemiology Data: The incidences and patient pool of Obstructive Sleep Apnea (OSA)
- Competitive Assessment: An in-depth assessment of market shares and company share analysis of the key players forecasted till 2019, along with details of the strategies and manufacturing capabilities of the leading players in the sleep apnea devices market
- Product/Brand Perception Analysis: A comprehensive study of customers’ perceptions and behavior through our inbuilt social connect tool (digital marketing language) checking the virality and tonality of blogs
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET SEGMENTATION & COVERAGE
1.3 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 INTEGRATED ECOSYSTEM OF SLEEP APNEA DEVICES MARKET
2.2 ARRIVING AT THE EUROPEAN SLEEP APNEA MARKET SIZE
2.2.1 TOP-DOWN APPROACH
2.3 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.1.1 STAGES OF SLEEP
4.1.1.1 Sleep Cycle
4.1.2 SLEEP DISORDERS
4.1.3 SLEEP APNEA
4.1.4 AN ANATOMY OF A SLEEP APNEA EPISODE
4.1.5 CAUSES
4.1.5.1 Central Sleep Apnea (CSA)
4.1.5.2 Obstructive Sleep Apnea (OSA)
4.1.6 SIGNS & SYMPTOMS
4.1.6.1 Central Sleep Apnea
4.1.6.2 Obstructive Sleep Apnea(OSA)
4.1.6.3 Signs & Symptoms in Children
4.1.7 RISK FACTORS
4.1.7.1 Central Sleep Apnea
4.1.7.2 Obstructive Sleep Apnea (OSA)
4.1.8 DIAGNOSIS
4.1.8.1 Sleep Apnea Diagnosis & Sleep Recording Test
4.1.9 TREATMENT OPTIONS
4.2 SLEEP APNEA DEVICES MARKET: COMPARISON WITH PARENT MARKET
4.3 MARKET DRIVERS AND INHIBITORS
4.4 KEY MARKET DYNAMICS
5 EUROPEAN SLEEP APNEA DEVICES MARKET, BY TYPE
5.1 INTRODUCTION
5.2 EUROPEAN SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE
5.2.1 HOME SLEEP TESTING
5.3 SLEEP LABS
5.4 TWO-CHANNEL SCREENING SYSTEM
5.5 SINGLE CHANNEL SCREENING SYSTEMS
5.6 SINGLE CHANNEL SCREENING DEVICES, BY TYPES
5.7 ACTIGRAPHY SYSTEMS
5.8 RESPIRATORY POLYGRAPHS
5.9 EUROPEAN SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE OF PRODUCT
5.9.1 PAP DEVICES
5.9.1.1 CPAP Devices
5.9.1.2 APAP Devices
5.9.1.3 Bi-level Devices
5.9.2 ADAPTIVE SERVO-VENTILATION (ASV)
5.9.3 AIRWAY CLEARANCE SYSTEMS
5.9.4 OXYGEN DEVICES
5.9.4.1 Concentrators
5.9.4.2 Home Oxygen Filling Systems
5.9.4.3 Liquid Portable Oxygen
5.9.5 ORAL APPLIANCE
5.9.5.1 Mandibular Advancement Device (MAD)
5.9.5.2 Tongue Retaining Device (TRD)
5.9.6 MASKS
5.9.6.1 Full Face Masks
5.9.6.2 Nasal Masks
5.9.6.3 Nasal Pillow Masks
5.9.6.4 Oral Masks
6 EUROPEAN SLEEP APNEA DEVICES MARKET, BY COUNTRY
6.1 INTRODUCTION
6.2 GERMANY SLEEP APNEA DEVICES MARKET
6.2.1 GERMANY SLEEP APNEA DIAGNOSTIC DEVICES MARKET
6.2.2 GERMANY SLEEP APNEA THERAPEUTIC DEVICES MARKET
6.3 FRANCE SLEEP APNEA DEVICES MARKET
6.3.1 FRANCE SLEEP APNEA DIAGNOSTIC DEVICES MARKET
6.3.2 FRANCE SLEEP APNEA THERAPEUTIC DEVICES MARKET
6.3.3 U.K. SLEEP APNEA DEVICES MARKET
6.3.4 U.K. SLEEP APNEA DIAGNOSTIC DEVICES MARKET
6.3.5 ITALY SLEEP APNEA DEVICES MARKET
6.3.6 ITALY SLEEP APNEA THERAPEUTIC DEVICES MARKET
6.4 SPAIN SLEEP APNEA DEVICES MARKET
7 EUROPEAN SLEEP APNEA DEVICES MARKET: COMPETITIVE LANDSCAPE
7.1 MARKET SHARES
7.1.1 EUROPEAN SLEEP APNEA MARKET, BY COMPANY, 2014
7.2 EUROPEAN SLEEP APNEA DEVICES MARKET: COMPANY SHARE ANALYSIS
7.3 MERGERS & ACQUISITIONS
7.4 NEW PRODUCT LAUNCH/DEVELOPMENT
7.5 PARTNERSHIPS
8 EUROPEAN SLEEP APNEA DEVICES MARKET, BY COMPANY
(Overview, Financials, Products & Services, Strategy, and Developments)*
8.1 BMC MEDICAL CO., LTD.
8.2 CAREFUSION CORPORATION
8.3 COMPUMEDICS LIMITED
8.4 FISHER AND PAYKEL HEALTHCARE LTD.
8.5 NATUS MEDICAL, INC.
8.6 PHILIPS RESPIRONICS (SUBSIDIARY OF PHILIPS HEALTHCARE LTD.)
8.7 RESMED, INC.
8.8 WEINMANN MEDICAL DEVICES GMBH & CO. KG
8.9 AMBULATORY MONITORING, INC.
8.10 NONIN MEDICAL
8.11 ITAMAR MEDICAL, LTD.
8.12 DEVILBISS HEALTHCARE
8.13 SOMNOMEDICS GMBH
8.14 NIHON KOHDEN
*(Details on overview, financials, product & services, strategy, and developments might not be captured in case of unlisted company)
9 APPENDIX
9.1 CUSTOMIZATION OPTIONS
9.1.1 EPIDEMIOLOGY DATA
9.1.2 SURGEONS/PHYSICIANS PERCEPTION ANALYSIS
9.1.3 REGULATORY FRAMEWORK
9.1.4 IMPACT ANALYSIS
9.1.5 COMPETITIVE INTELLIGENCE:
9.2 RELATED REPORTS
9.3 RT: REAL TIME MARKET INTELLIGENCE
9.3.1 RT SNAPSHOTS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET SEGMENTATION & COVERAGE
1.3 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 INTEGRATED ECOSYSTEM OF SLEEP APNEA DEVICES MARKET
2.2 ARRIVING AT THE EUROPEAN SLEEP APNEA MARKET SIZE
2.2.1 TOP-DOWN APPROACH
2.3 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 MARKET OVERVIEW
4.1 INTRODUCTION
4.1.1 STAGES OF SLEEP
4.1.1.1 Sleep Cycle
4.1.2 SLEEP DISORDERS
4.1.3 SLEEP APNEA
4.1.4 AN ANATOMY OF A SLEEP APNEA EPISODE
4.1.5 CAUSES
4.1.5.1 Central Sleep Apnea (CSA)
4.1.5.2 Obstructive Sleep Apnea (OSA)
4.1.6 SIGNS & SYMPTOMS
4.1.6.1 Central Sleep Apnea
4.1.6.2 Obstructive Sleep Apnea(OSA)
4.1.6.3 Signs & Symptoms in Children
4.1.7 RISK FACTORS
4.1.7.1 Central Sleep Apnea
4.1.7.2 Obstructive Sleep Apnea (OSA)
4.1.8 DIAGNOSIS
4.1.8.1 Sleep Apnea Diagnosis & Sleep Recording Test
4.1.9 TREATMENT OPTIONS
4.2 SLEEP APNEA DEVICES MARKET: COMPARISON WITH PARENT MARKET
4.3 MARKET DRIVERS AND INHIBITORS
4.4 KEY MARKET DYNAMICS
5 EUROPEAN SLEEP APNEA DEVICES MARKET, BY TYPE
5.1 INTRODUCTION
5.2 EUROPEAN SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE
5.2.1 HOME SLEEP TESTING
5.3 SLEEP LABS
5.4 TWO-CHANNEL SCREENING SYSTEM
5.5 SINGLE CHANNEL SCREENING SYSTEMS
5.6 SINGLE CHANNEL SCREENING DEVICES, BY TYPES
5.7 ACTIGRAPHY SYSTEMS
5.8 RESPIRATORY POLYGRAPHS
5.9 EUROPEAN SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE OF PRODUCT
5.9.1 PAP DEVICES
5.9.1.1 CPAP Devices
5.9.1.2 APAP Devices
5.9.1.3 Bi-level Devices
5.9.2 ADAPTIVE SERVO-VENTILATION (ASV)
5.9.3 AIRWAY CLEARANCE SYSTEMS
5.9.4 OXYGEN DEVICES
5.9.4.1 Concentrators
5.9.4.2 Home Oxygen Filling Systems
5.9.4.3 Liquid Portable Oxygen
5.9.5 ORAL APPLIANCE
5.9.5.1 Mandibular Advancement Device (MAD)
5.9.5.2 Tongue Retaining Device (TRD)
5.9.6 MASKS
5.9.6.1 Full Face Masks
5.9.6.2 Nasal Masks
5.9.6.3 Nasal Pillow Masks
5.9.6.4 Oral Masks
6 EUROPEAN SLEEP APNEA DEVICES MARKET, BY COUNTRY
6.1 INTRODUCTION
6.2 GERMANY SLEEP APNEA DEVICES MARKET
6.2.1 GERMANY SLEEP APNEA DIAGNOSTIC DEVICES MARKET
6.2.2 GERMANY SLEEP APNEA THERAPEUTIC DEVICES MARKET
6.3 FRANCE SLEEP APNEA DEVICES MARKET
6.3.1 FRANCE SLEEP APNEA DIAGNOSTIC DEVICES MARKET
6.3.2 FRANCE SLEEP APNEA THERAPEUTIC DEVICES MARKET
6.3.3 U.K. SLEEP APNEA DEVICES MARKET
6.3.4 U.K. SLEEP APNEA DIAGNOSTIC DEVICES MARKET
6.3.5 ITALY SLEEP APNEA DEVICES MARKET
6.3.6 ITALY SLEEP APNEA THERAPEUTIC DEVICES MARKET
6.4 SPAIN SLEEP APNEA DEVICES MARKET
7 EUROPEAN SLEEP APNEA DEVICES MARKET: COMPETITIVE LANDSCAPE
7.1 MARKET SHARES
7.1.1 EUROPEAN SLEEP APNEA MARKET, BY COMPANY, 2014
7.2 EUROPEAN SLEEP APNEA DEVICES MARKET: COMPANY SHARE ANALYSIS
7.3 MERGERS & ACQUISITIONS
7.4 NEW PRODUCT LAUNCH/DEVELOPMENT
7.5 PARTNERSHIPS
8 EUROPEAN SLEEP APNEA DEVICES MARKET, BY COMPANY
(Overview, Financials, Products & Services, Strategy, and Developments)*
8.1 BMC MEDICAL CO., LTD.
8.2 CAREFUSION CORPORATION
8.3 COMPUMEDICS LIMITED
8.4 FISHER AND PAYKEL HEALTHCARE LTD.
8.5 NATUS MEDICAL, INC.
8.6 PHILIPS RESPIRONICS (SUBSIDIARY OF PHILIPS HEALTHCARE LTD.)
8.7 RESMED, INC.
8.8 WEINMANN MEDICAL DEVICES GMBH & CO. KG
8.9 AMBULATORY MONITORING, INC.
8.10 NONIN MEDICAL
8.11 ITAMAR MEDICAL, LTD.
8.12 DEVILBISS HEALTHCARE
8.13 SOMNOMEDICS GMBH
8.14 NIHON KOHDEN
*(Details on overview, financials, product & services, strategy, and developments might not be captured in case of unlisted company)
9 APPENDIX
9.1 CUSTOMIZATION OPTIONS
9.1.1 EPIDEMIOLOGY DATA
9.1.2 SURGEONS/PHYSICIANS PERCEPTION ANALYSIS
9.1.3 REGULATORY FRAMEWORK
9.1.4 IMPACT ANALYSIS
9.1.5 COMPETITIVE INTELLIGENCE:
9.2 RELATED REPORTS
9.3 RT: REAL TIME MARKET INTELLIGENCE
9.3.1 RT SNAPSHOTS
LIST OF TABLES
TABLE 1 EUROPEAN SLEEP APNEA DEVICES MARKET: COMPARISON WITH PARENT MARKET, 2013–2019 (USD MN)
TABLE 2 EUROPEAN SLEEP APNEA MARKET: DRIVERS AND INHIBITORS
TABLE 3 EUROPEAN SLEEP APNEA DEVICES MARKET, BY SEGMENT, 2013–2019 (USD MN)
TABLE 4 EUROPEAN SLEEP APNEA DEVICES MARKET, BY COUNTRY, 2013–2019 (USD MN)
TABLE 5 EUROPEAN SLEEP APNEA DEVICES MARKET, BY SEGMENT, 2013–2019 (USD MN)
TABLE 6 EUROPEAN SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY COUNTRY, 2013–2019 (USD MN)
TABLE 7 EUROPEAN SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2013–2019 (USD MN)
TABLE 8 EUROPEAN SLEEP APNEA HOME SLEEP TESTING MARKET, BY COUNTRY, 2013–2019 (USD MN)
TABLE 9 EUROPEAN SLEEP APNEA SLEEP LABS MARKET, BY COUNTRY, 2013–2019 (USD MN)
TABLE 10 EUROPEAN SLEEP APNEA TWO-CHANNEL SCREENING SYSTEMS MARKET, BY COUNTRY, 2013–2019 (USD MN)
TABLE 11 EUROPEAN SLEEP APNEA SINGLE CHANNEL SCREENING SYSTEMS MARKET, BY COUNTRY, 2013–2019 (USD MN)
TABLE 12 EUROPEAN SLEEP APNEA SINGLE CHANNEL SCREENING SYSTEMS MARKET, BY TYPE, 2013–2019 (USD MN)
TABLE 13 EUROPEAN SLEEP APNEA HAND-HELD PULSE OXIMETERS, BY COUNTRY, 2013–2019 (USD MN)
TABLE 14 EUROPEAN SLEEP APNEA FINGERTIP PULSE OXIMETERS, BY COUNTRY, 2013–2019 (USD MN)
TABLE 15 EUROPEAN SLEEP APNEA TABLETOP PULSE OXIMETERS, BY COUNTRY, 2013–2019 (USD MN)
TABLE 16 EUROPEAN SLEEP APNEA WRIST-WORN PULSE OXIMETERS, BY COUNTRY, 2013–2019 (USD MN)
TABLE 17 EUROPEAN SLEEP APNEA ACTIGRAPHY SYSTEMS, COUNTRY, 2013–2019 (USD MN)
TABLE 18 EUROPEAN SLEEP APNEA RESPIRATORY POLYGRAPHS DEVICES MARKET, BY COUNTRY, 2013–2019 (USD MN)
TABLE 19 EUROPEAN SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY COUNTRY, 2013–2019 (USD MN)
TABLE 20 EUROPEAN SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2013–2019 (USD MN)
TABLE 21 EUROPEAN SLEEP APNEA PAP DEVICES MARKET, BY COUNTRY, 2013–2019 (USD MN)
TABLE 22 EUROPEAN SLEEP APNEA PAP DEVICES, BY TYPE, 2013–2019 (USD MN)
TABLE 23 EUROPEAN SLEEP APNEA CPAP DEVICES, BY COUNTRY, 2013–2019 (USD MN)
TABLE 24 EUROPEAN SLEEP APNEA APAP DEVICES, BY GEOGRAPHY, 2013–2019 (USD MN)
TABLE 25 EUROPEAN SLEEP APNEA BILEVEL DEVICES, BY COUNTRY, 2013–2019 (USD MN)
TABLE 26 EUROPEAN ADAPTIVE SERVO-VENTILATION (ASV), BY COUNTRY, 2013–2019 (USD MN)
TABLE 27 EUROPEAN SLEEP APNEA AIRWAY CLEARANCE SYSTEM, BY COUNTRY, 2013–2019 (USD MN)
TABLE 28 EUROPEAN SLEEP APNEA OXYGEN DEVICES, BY COUNTRY, 2013–2019 (USD MN)
TABLE 29 EUROPEAN SLEEP APNEA OXYGEN DEVICES, BY TYPE, 2013–2019 (USD MN)
TABLE 30 EUROPEAN SLEEP APNEA CONCENTRATORS, BY COUNTRY, 2013–2019 (USD MN)
TABLE 31 EUROPEAN SLEEP APNEA HOME OXYGEN FILLING SYSTEMS, BY COUNTRY, 2013–2019 (USD MN)
TABLE 32 EUROPEAN SLEEP APNEA LIQUID PORTABLE OXYGEN, BY COUNTRY, 2013–2019 (USD MN)
TABLE 33 EUROPEAN SLEEP APNEA ORAL APPLIANCES, BY COUNTRY, 2013–2019 (USD MN)
TABLE 34 EUROPEAN SLEEP APNEA ORAL APPLIANCE, BY PRODUCT, 2013–2019 (USD MN)
TABLE 35 EUROPEAN SLEEP APNEA MANDIBULAR ADVANCEMENT DEVICE (MAD), BY COUNTRY, 2013–2019 (USD MN)
TABLE 36 EUROPEAN SLEEP APNEA TONGUE RETAINING DEVICE (TRD), BY COUNTRY, 2013–2019 (USD MN)
TABLE 37 EUROPEAN SLEEP APNEA MASKS, BY COUNTRY, 2013–2019 (USD MN)
TABLE 38 EUROPEAN SLEEP APNEA MASKS, BY PRODUCT, 2013–2019 (USD MN)
TABLE 39 EUROPEAN SLEEP APNEA FULL FACE MASKS, BY COUNTRY, 2013–2019 (USD MN)
TABLE 40 EUROPEAN SLEEP APNEA NASAL MASKS, BY COUNTRY, 2013–2019 (USD MN)
TABLE 41 EUROPEAN SLEEP APNEA NASAL PILLOW MASKS, BY COUNTRY, 2013–2019 (USD MN)
TABLE 42 EUROPEAN SLEEP APNEA ORAL MASKS, BY COUNTRY, 2013–2019 (USD MN)
TABLE 43 EUROPEAN SLEEP APNEA DEVICES MARKET, BY COUNTRY, 2013–2019 (USD MN)
TABLE 44 GERMANY SLEEP APNEA DEVICES MARKET, BY SEGMENT, 2013–2019 (USD MN)
TABLE 45 GERMANY SLEEP APNEA DIAGNOSTIC DEVICES MARKET, 2013–2019 (USD MN)
TABLE 46 GERMANY SLEEP APNEA THERAPEUTIC DEVICES MARKET, 2013–2019 (USD MN)
TABLE 47 FRANCE SLEEP APNEA DEVICES MARKET, BY SEGMENT, 2013–2019 (USD MN)
TABLE 48 FRANCE SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY SEGMENT, 2013–2019 (USD MN)
TABLE 49 FRANCE SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY SEGMENT, 2013–2019 (USD MN)
TABLE 50 U.K. SLEEP APNEA DEVICES MARKET, BY SEGMENT, 2013–2019 (USD MN)
TABLE 51 U.K. SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2013–2019 (USD MN)
TABLE 52 U.K. SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY SEGMENT, 2013–2019 (USD MN)
TABLE 53 ITALY SLEEP APNEA DEVICES MARKET, BY SEGMENT, 2013–2019 (USD MN)
TABLE 54 ITALY SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY SEGMENT (USD MN)
TABLE 55 ITALY SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2013–2019 (USD MN)
TABLE 56 SPAIN SLEEP APNEA DEVICES MARKET, BY SEGMENT, 2013–2019 (USD MN)
TABLE 57 SPAIN SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2013–2019 (USD MN)
TABLE 58 SPAIN SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2013–2019 (USD MN)
TABLE 59 REST OF EUROPE SLEEP APNEA DEVICES MARKET, BY SEGMENT, 2013–2019 (USD MN)
TABLE 60 REST OF EUROPE SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2013–2019 (USD MN)
TABLE 61 REST OF EUROPE SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2013–2019 (USD MN)
TABLE 62 SLEEP APNEA DEVICES MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
TABLE 63 SLEEP APNEA DEVICES MARKET: MERGERS & ACQUISITIONS
TABLE 64 EUROPEAN SLEEP APNEA DEVICES MARKET: NEW PRODUCT LAUNCH/DEVELOPMENT
TABLE 65 EUROPEAN SLEEP APNEA DEVICES MARKET: PARTNERSHIPS
TABLE 66 CAREFUSION CORPORATION: KEY FINANCIALS, 2011–2013 (USD MN)
TABLE 67 COMPUMEDICS LIMITED: KEY FINANCIALS, 2011–2013 (USD MN)
TABLE 68 FISHER AND PAYKEL HEALTHCARE: KEY FINANCIALS, 2011–2013 (USD MN)
TABLE 69 NATUS MEDICAL, INC.: KEY FINANCIALS, 2011–2013 (USD MN)
TABLE 70 PHILIPS RESPIRONICS: KEY FINANCIALS, 2011–2013 (USD MN)
TABLE 71 RESMED, INC.: KEY FINANCIALS, 2011–2013 (USD MN)
TABLE 1 EUROPEAN SLEEP APNEA DEVICES MARKET: COMPARISON WITH PARENT MARKET, 2013–2019 (USD MN)
TABLE 2 EUROPEAN SLEEP APNEA MARKET: DRIVERS AND INHIBITORS
TABLE 3 EUROPEAN SLEEP APNEA DEVICES MARKET, BY SEGMENT, 2013–2019 (USD MN)
TABLE 4 EUROPEAN SLEEP APNEA DEVICES MARKET, BY COUNTRY, 2013–2019 (USD MN)
TABLE 5 EUROPEAN SLEEP APNEA DEVICES MARKET, BY SEGMENT, 2013–2019 (USD MN)
TABLE 6 EUROPEAN SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY COUNTRY, 2013–2019 (USD MN)
TABLE 7 EUROPEAN SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2013–2019 (USD MN)
TABLE 8 EUROPEAN SLEEP APNEA HOME SLEEP TESTING MARKET, BY COUNTRY, 2013–2019 (USD MN)
TABLE 9 EUROPEAN SLEEP APNEA SLEEP LABS MARKET, BY COUNTRY, 2013–2019 (USD MN)
TABLE 10 EUROPEAN SLEEP APNEA TWO-CHANNEL SCREENING SYSTEMS MARKET, BY COUNTRY, 2013–2019 (USD MN)
TABLE 11 EUROPEAN SLEEP APNEA SINGLE CHANNEL SCREENING SYSTEMS MARKET, BY COUNTRY, 2013–2019 (USD MN)
TABLE 12 EUROPEAN SLEEP APNEA SINGLE CHANNEL SCREENING SYSTEMS MARKET, BY TYPE, 2013–2019 (USD MN)
TABLE 13 EUROPEAN SLEEP APNEA HAND-HELD PULSE OXIMETERS, BY COUNTRY, 2013–2019 (USD MN)
TABLE 14 EUROPEAN SLEEP APNEA FINGERTIP PULSE OXIMETERS, BY COUNTRY, 2013–2019 (USD MN)
TABLE 15 EUROPEAN SLEEP APNEA TABLETOP PULSE OXIMETERS, BY COUNTRY, 2013–2019 (USD MN)
TABLE 16 EUROPEAN SLEEP APNEA WRIST-WORN PULSE OXIMETERS, BY COUNTRY, 2013–2019 (USD MN)
TABLE 17 EUROPEAN SLEEP APNEA ACTIGRAPHY SYSTEMS, COUNTRY, 2013–2019 (USD MN)
TABLE 18 EUROPEAN SLEEP APNEA RESPIRATORY POLYGRAPHS DEVICES MARKET, BY COUNTRY, 2013–2019 (USD MN)
TABLE 19 EUROPEAN SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY COUNTRY, 2013–2019 (USD MN)
TABLE 20 EUROPEAN SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2013–2019 (USD MN)
TABLE 21 EUROPEAN SLEEP APNEA PAP DEVICES MARKET, BY COUNTRY, 2013–2019 (USD MN)
TABLE 22 EUROPEAN SLEEP APNEA PAP DEVICES, BY TYPE, 2013–2019 (USD MN)
TABLE 23 EUROPEAN SLEEP APNEA CPAP DEVICES, BY COUNTRY, 2013–2019 (USD MN)
TABLE 24 EUROPEAN SLEEP APNEA APAP DEVICES, BY GEOGRAPHY, 2013–2019 (USD MN)
TABLE 25 EUROPEAN SLEEP APNEA BILEVEL DEVICES, BY COUNTRY, 2013–2019 (USD MN)
TABLE 26 EUROPEAN ADAPTIVE SERVO-VENTILATION (ASV), BY COUNTRY, 2013–2019 (USD MN)
TABLE 27 EUROPEAN SLEEP APNEA AIRWAY CLEARANCE SYSTEM, BY COUNTRY, 2013–2019 (USD MN)
TABLE 28 EUROPEAN SLEEP APNEA OXYGEN DEVICES, BY COUNTRY, 2013–2019 (USD MN)
TABLE 29 EUROPEAN SLEEP APNEA OXYGEN DEVICES, BY TYPE, 2013–2019 (USD MN)
TABLE 30 EUROPEAN SLEEP APNEA CONCENTRATORS, BY COUNTRY, 2013–2019 (USD MN)
TABLE 31 EUROPEAN SLEEP APNEA HOME OXYGEN FILLING SYSTEMS, BY COUNTRY, 2013–2019 (USD MN)
TABLE 32 EUROPEAN SLEEP APNEA LIQUID PORTABLE OXYGEN, BY COUNTRY, 2013–2019 (USD MN)
TABLE 33 EUROPEAN SLEEP APNEA ORAL APPLIANCES, BY COUNTRY, 2013–2019 (USD MN)
TABLE 34 EUROPEAN SLEEP APNEA ORAL APPLIANCE, BY PRODUCT, 2013–2019 (USD MN)
TABLE 35 EUROPEAN SLEEP APNEA MANDIBULAR ADVANCEMENT DEVICE (MAD), BY COUNTRY, 2013–2019 (USD MN)
TABLE 36 EUROPEAN SLEEP APNEA TONGUE RETAINING DEVICE (TRD), BY COUNTRY, 2013–2019 (USD MN)
TABLE 37 EUROPEAN SLEEP APNEA MASKS, BY COUNTRY, 2013–2019 (USD MN)
TABLE 38 EUROPEAN SLEEP APNEA MASKS, BY PRODUCT, 2013–2019 (USD MN)
TABLE 39 EUROPEAN SLEEP APNEA FULL FACE MASKS, BY COUNTRY, 2013–2019 (USD MN)
TABLE 40 EUROPEAN SLEEP APNEA NASAL MASKS, BY COUNTRY, 2013–2019 (USD MN)
TABLE 41 EUROPEAN SLEEP APNEA NASAL PILLOW MASKS, BY COUNTRY, 2013–2019 (USD MN)
TABLE 42 EUROPEAN SLEEP APNEA ORAL MASKS, BY COUNTRY, 2013–2019 (USD MN)
TABLE 43 EUROPEAN SLEEP APNEA DEVICES MARKET, BY COUNTRY, 2013–2019 (USD MN)
TABLE 44 GERMANY SLEEP APNEA DEVICES MARKET, BY SEGMENT, 2013–2019 (USD MN)
TABLE 45 GERMANY SLEEP APNEA DIAGNOSTIC DEVICES MARKET, 2013–2019 (USD MN)
TABLE 46 GERMANY SLEEP APNEA THERAPEUTIC DEVICES MARKET, 2013–2019 (USD MN)
TABLE 47 FRANCE SLEEP APNEA DEVICES MARKET, BY SEGMENT, 2013–2019 (USD MN)
TABLE 48 FRANCE SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY SEGMENT, 2013–2019 (USD MN)
TABLE 49 FRANCE SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY SEGMENT, 2013–2019 (USD MN)
TABLE 50 U.K. SLEEP APNEA DEVICES MARKET, BY SEGMENT, 2013–2019 (USD MN)
TABLE 51 U.K. SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2013–2019 (USD MN)
TABLE 52 U.K. SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY SEGMENT, 2013–2019 (USD MN)
TABLE 53 ITALY SLEEP APNEA DEVICES MARKET, BY SEGMENT, 2013–2019 (USD MN)
TABLE 54 ITALY SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY SEGMENT (USD MN)
TABLE 55 ITALY SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2013–2019 (USD MN)
TABLE 56 SPAIN SLEEP APNEA DEVICES MARKET, BY SEGMENT, 2013–2019 (USD MN)
TABLE 57 SPAIN SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2013–2019 (USD MN)
TABLE 58 SPAIN SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2013–2019 (USD MN)
TABLE 59 REST OF EUROPE SLEEP APNEA DEVICES MARKET, BY SEGMENT, 2013–2019 (USD MN)
TABLE 60 REST OF EUROPE SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2013–2019 (USD MN)
TABLE 61 REST OF EUROPE SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2013–2019 (USD MN)
TABLE 62 SLEEP APNEA DEVICES MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
TABLE 63 SLEEP APNEA DEVICES MARKET: MERGERS & ACQUISITIONS
TABLE 64 EUROPEAN SLEEP APNEA DEVICES MARKET: NEW PRODUCT LAUNCH/DEVELOPMENT
TABLE 65 EUROPEAN SLEEP APNEA DEVICES MARKET: PARTNERSHIPS
TABLE 66 CAREFUSION CORPORATION: KEY FINANCIALS, 2011–2013 (USD MN)
TABLE 67 COMPUMEDICS LIMITED: KEY FINANCIALS, 2011–2013 (USD MN)
TABLE 68 FISHER AND PAYKEL HEALTHCARE: KEY FINANCIALS, 2011–2013 (USD MN)
TABLE 69 NATUS MEDICAL, INC.: KEY FINANCIALS, 2011–2013 (USD MN)
TABLE 70 PHILIPS RESPIRONICS: KEY FINANCIALS, 2011–2013 (USD MN)
TABLE 71 RESMED, INC.: KEY FINANCIALS, 2011–2013 (USD MN)
LIST OF FIGURES
FIGURE 1 EUROPEAN SLEEP APNEA DEVICES MARKET: SEGMENTATION & COVERAGE
FIGURE 2 SLEEP APNEA DEVICES MARKET: INTEGRATED ECOSYSTEM
FIGURE 3 TOP-DOWN APPROACH
FIGURE 4 EUROPEAN SLEEP APNEA DEVICES MARKET SEGMENTS, BY COUNTRY, 2014 (USD MN)
FIGURE 5 EUROPEAN SLEEP APNEA DEVICES MARKET, BY SEGMENT, 2013–2019 (USD MN)
FIGURE 6 EUROPEAN SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY GEOGRAPHY, 2013–2019 (USD MN)
FIGURE 7 EUROPEAN SLEEP APNEA HOME SLEEP TESTING MARKET, BY COUNTRY, 2013–2019 (USD MN)
FIGURE 8 EUROPEAN SLEEP APNEA SLEEP LABS MARKET, BY COUNTRY, 2013–2019 (USD MN)
FIGURE 9 EUROPEAN SLEEP APNEA TWO-CHANNEL SCREENING SYSTEMS MARKET, BY COUNTRY, 2013–2019 (USD MN)
FIGURE 10 EUROPEAN SLEEP APNEA SINGLE CHANNEL SCREENING SYSTEMS MARKET, BY COUNTRY, 2013–2019 (USD MN)
FIGURE 11 EUROPEAN SLEEP APNEA ACTIGRAPHY SYSTEMS MARKET, BY COUNTRY, 2013–2019 (USD MN)
FIGURE 12 EUROPEAN SLEEP APNEA RESPIRATORY POLYGRAPHS MARKET, BY COUNTRY, 2013–2019 (USD MN)
FIGURE 13 EUROPEAN SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY COUNTRY, 2013–2019 (USD MN)
FIGURE 14 EUROPEAN SLEEP APNEA PAP DEVICES MARKET, BY COUNTRY, 2013–2019 (USD MN)
FIGURE 15 EUROPEAN SLEEP APNEA ADAPTIVE SERVO VENTILATION MARKET, BY COUNTRY, 2013–2019 (USD MN)
FIGURE 16 EUROPEAN SLEEP APNEA AIRWAY CLEARANCE SYSTEMS MARKET, BY COUNTRY, 2013–2019 (USD MN)
FIGURE 17 EUROPEAN SLEEP APNEA OXYGEN DEVICES MARKET, BY COUNTRY, 2013–2019 (USD MN)
FIGURE 18 EUROPEAN SLEEP APNEA ORAL APPLIANCES MARKET, BY COUNTRY, 2013–2019 (USD MN)
FIGURE 19 EUROPEAN SLEEP APNEA MASKS MARKET, BY COUNTRY, 2013–2019 (USD MN)
FIGURE 20 EUROPEAN SLEEP APNEA DEVICES MARKET: GROWTH ANALYSIS, BY COUNTRY, 2013–2019 (USD MN)
FIGURE 21 GERMANY SLEEP APNEA DEVICES MARKET OVERVIEW, 2014 & 2019 (%)
FIGURE 22 GERMANY SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2013–2019 (USD MN)
FIGURE 23 GERMANY SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2013–2019 (USD MN)
FIGURE 24 FRANCE SLEEP APNEA DEVICES MARKET OVERVIEW, 2014 & 2019 (%)
FIGURE 25 FRANCE SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY SEGMENT, 2013–2019 (USD MN)
FIGURE 26 FRANCE SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY SEGMENT, 2013–2019 (USD MN)
FIGURE 27 U.K. SLEEP APNEA DEVICES MARKET OVERVIEW, 2014 & 2019 (%)
FIGURE 28 U.K. SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2013–2019 (USD MN)
FIGURE 29 U.K. SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2013–2019 (USD MN)
FIGURE 30 ITALY SLEEP APNEA DEVICES MARKET OVERVIEW, 2014 & 2019 (%)
FIGURE 31 ITALY SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2013–2019 (USD MN)
FIGURE 32 ITALY SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2013–2019 (USD MN)
FIGURE 33 SPAIN SLEEP APNEA DEVICES MARKET OVERVIEW, 2014 & 2019 (%)
FIGURE 34 SPAIN SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2013–2019 (USD MN)
FIGURE 35 SPAIN SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2013–2019 (USD MN)
FIGURE 36 REST OF EUROPE SLEEP APNEA DEVICES MARKET OVERVIEW, 2014 & 2019 (%)
FIGURE 37 REST OF EUROPE SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2013–2019 (USD MN)
FIGURE 38 REST OF EUROPE SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2013–2019 (USD MN)
FIGURE 39 EUROPEAN SLEEP APNEA DEVICES MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
FIGURE 40 CAREFUSION CORPORATION REVENUE MIX, 2013 (%)
FIGURE 41 CONTRIBUTION OF MEDICAL SYSTEMS SEGMENT TOWARDS COMPANY REVENUES, 2011-2013 (USD MN)
FIGURE 42 FISHER AND PAYKEL HEALTHCARE LTD.: REVENUE MIX, 2013 (%)
FIGURE 43 CONTRIBUTION OF OBSTRUCTIVE SLEEP APNEA SEGMENT TOWARDS COMPANY REVENUES, 2011-2013 (USD MN)
FIGURE 44 PHILIPS RESPIRONICS: REVENUE MIX, 2013 (%)
FIGURE 45 CONTRIBUTION OF HEALTHCARE SEGMENT TOWARDS COMPANY REVENUES, 2011-2013 (USD MN)
FIGURE 46 RESMED, INC.: REVENUE MIX, 2013 (%)
FIGURE 47 CONTRIBUTION OF MASK SYSTEMS, MOTORS, ACCESSORIES SEGMENT TOWARDS COMPANY REVENUES, 2011-2013 (USD MN)
FIGURE 48 NIHON KOHDEN: REVENUE MIX, 2013 (%)
FIGURE 1 EUROPEAN SLEEP APNEA DEVICES MARKET: SEGMENTATION & COVERAGE
FIGURE 2 SLEEP APNEA DEVICES MARKET: INTEGRATED ECOSYSTEM
FIGURE 3 TOP-DOWN APPROACH
FIGURE 4 EUROPEAN SLEEP APNEA DEVICES MARKET SEGMENTS, BY COUNTRY, 2014 (USD MN)
FIGURE 5 EUROPEAN SLEEP APNEA DEVICES MARKET, BY SEGMENT, 2013–2019 (USD MN)
FIGURE 6 EUROPEAN SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY GEOGRAPHY, 2013–2019 (USD MN)
FIGURE 7 EUROPEAN SLEEP APNEA HOME SLEEP TESTING MARKET, BY COUNTRY, 2013–2019 (USD MN)
FIGURE 8 EUROPEAN SLEEP APNEA SLEEP LABS MARKET, BY COUNTRY, 2013–2019 (USD MN)
FIGURE 9 EUROPEAN SLEEP APNEA TWO-CHANNEL SCREENING SYSTEMS MARKET, BY COUNTRY, 2013–2019 (USD MN)
FIGURE 10 EUROPEAN SLEEP APNEA SINGLE CHANNEL SCREENING SYSTEMS MARKET, BY COUNTRY, 2013–2019 (USD MN)
FIGURE 11 EUROPEAN SLEEP APNEA ACTIGRAPHY SYSTEMS MARKET, BY COUNTRY, 2013–2019 (USD MN)
FIGURE 12 EUROPEAN SLEEP APNEA RESPIRATORY POLYGRAPHS MARKET, BY COUNTRY, 2013–2019 (USD MN)
FIGURE 13 EUROPEAN SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY COUNTRY, 2013–2019 (USD MN)
FIGURE 14 EUROPEAN SLEEP APNEA PAP DEVICES MARKET, BY COUNTRY, 2013–2019 (USD MN)
FIGURE 15 EUROPEAN SLEEP APNEA ADAPTIVE SERVO VENTILATION MARKET, BY COUNTRY, 2013–2019 (USD MN)
FIGURE 16 EUROPEAN SLEEP APNEA AIRWAY CLEARANCE SYSTEMS MARKET, BY COUNTRY, 2013–2019 (USD MN)
FIGURE 17 EUROPEAN SLEEP APNEA OXYGEN DEVICES MARKET, BY COUNTRY, 2013–2019 (USD MN)
FIGURE 18 EUROPEAN SLEEP APNEA ORAL APPLIANCES MARKET, BY COUNTRY, 2013–2019 (USD MN)
FIGURE 19 EUROPEAN SLEEP APNEA MASKS MARKET, BY COUNTRY, 2013–2019 (USD MN)
FIGURE 20 EUROPEAN SLEEP APNEA DEVICES MARKET: GROWTH ANALYSIS, BY COUNTRY, 2013–2019 (USD MN)
FIGURE 21 GERMANY SLEEP APNEA DEVICES MARKET OVERVIEW, 2014 & 2019 (%)
FIGURE 22 GERMANY SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2013–2019 (USD MN)
FIGURE 23 GERMANY SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2013–2019 (USD MN)
FIGURE 24 FRANCE SLEEP APNEA DEVICES MARKET OVERVIEW, 2014 & 2019 (%)
FIGURE 25 FRANCE SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY SEGMENT, 2013–2019 (USD MN)
FIGURE 26 FRANCE SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY SEGMENT, 2013–2019 (USD MN)
FIGURE 27 U.K. SLEEP APNEA DEVICES MARKET OVERVIEW, 2014 & 2019 (%)
FIGURE 28 U.K. SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2013–2019 (USD MN)
FIGURE 29 U.K. SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2013–2019 (USD MN)
FIGURE 30 ITALY SLEEP APNEA DEVICES MARKET OVERVIEW, 2014 & 2019 (%)
FIGURE 31 ITALY SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2013–2019 (USD MN)
FIGURE 32 ITALY SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2013–2019 (USD MN)
FIGURE 33 SPAIN SLEEP APNEA DEVICES MARKET OVERVIEW, 2014 & 2019 (%)
FIGURE 34 SPAIN SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2013–2019 (USD MN)
FIGURE 35 SPAIN SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2013–2019 (USD MN)
FIGURE 36 REST OF EUROPE SLEEP APNEA DEVICES MARKET OVERVIEW, 2014 & 2019 (%)
FIGURE 37 REST OF EUROPE SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY TYPE, 2013–2019 (USD MN)
FIGURE 38 REST OF EUROPE SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE, 2013–2019 (USD MN)
FIGURE 39 EUROPEAN SLEEP APNEA DEVICES MARKET: COMPANY SHARE ANALYSIS, 2014 (%)
FIGURE 40 CAREFUSION CORPORATION REVENUE MIX, 2013 (%)
FIGURE 41 CONTRIBUTION OF MEDICAL SYSTEMS SEGMENT TOWARDS COMPANY REVENUES, 2011-2013 (USD MN)
FIGURE 42 FISHER AND PAYKEL HEALTHCARE LTD.: REVENUE MIX, 2013 (%)
FIGURE 43 CONTRIBUTION OF OBSTRUCTIVE SLEEP APNEA SEGMENT TOWARDS COMPANY REVENUES, 2011-2013 (USD MN)
FIGURE 44 PHILIPS RESPIRONICS: REVENUE MIX, 2013 (%)
FIGURE 45 CONTRIBUTION OF HEALTHCARE SEGMENT TOWARDS COMPANY REVENUES, 2011-2013 (USD MN)
FIGURE 46 RESMED, INC.: REVENUE MIX, 2013 (%)
FIGURE 47 CONTRIBUTION OF MASK SYSTEMS, MOTORS, ACCESSORIES SEGMENT TOWARDS COMPANY REVENUES, 2011-2013 (USD MN)
FIGURE 48 NIHON KOHDEN: REVENUE MIX, 2013 (%)
